Results 51 to 60 of about 740,744 (261)
Nature Communications, 2023 Reconstructing the incidence of SARS-CoV-2 infection is central to understanding the state of the pandemic. Seroprevalence studies are often used to assess cumulative infections as they can identify asymptomatic infection.
Bernardo García-Carreras +10 more
doaj +1 more source
Microbiology Spectrum, 2022 Serological assays for SARS-CoV-2 antibodies must be validated for performance with a large panel of clinical specimens. Most existing assays utilize a single antigen target and may be subject to reduced diagnostic specificity.
Kaitlin F. Mitchell +11 more
doaj +1 more source
Annual Review of Medicine, 2023 COVID-19 can cause acute kidney injury and may cause or exacerbate chronic kidney diseases, including glomerular diseases. SARS-CoV-2 infection of kidney cells has been reported, but it remains unclear if viral infection of kidney cells causes disease.
Maureen, Brogan, Michael J, Ross
openaire +2 more sources
BMC Infectious Diseases, 2023 Background Symptomatic COVID-19 and Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 (PASC) or post-COVID conditions, have been widely reported in young, healthy people, but their prevalence has not yet been determined in student ...
Daisy Massey +7 more
doaj +1 more source
Cardiovascular disease and the impact of COVID‐19 [PDF]
Journal of Cardiac Surgery, 2020 Cardiovascular disease and the impact of COVID-19Running Head: COVID-19 and cardiovascularAnusha Yoganathan1, Menahel Sajjad1, Amer Harky1,2University of Liverpool, Liverpool, UKDepartment of Cardiothoracic Surgery, Liverpool Heart and Chest, Liverpool ...
Yoganathan, Anusha +2 more
openaire +2 more sources
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
COVID-19 is an emergent disease of aging [PDF]
Aging Cell, 2020 Abstract COVID-19 is an ongoing pandemic caused by the SARS-CoV-2 coronavirus that poses one of the greatest challenges to public health in recent years. SARS-CoV-2 is highly contagious and often leads to severe viral pneumonia with respiratory failure and death in the elderly and subjects with pre-existing conditions, but the reason ...
Didac Santesmasses +9 more
openaire +2 more sources
Design and analysis strategies for robust microbiome ageing research
FEBS Letters, EarlyView.The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
The Lancet Regional Health. Americas, 2021 Background: In the United States, Coronavirus Disease 2019 (COVID-19) deaths are captured through the National Notifiable Disease Surveillance System and death certificates reported to the National Vital Statistics System (NVSS).
A. Danielle Iuliano, Ph.D. +9 more
doaj +1 more source
Molecular Oncology, EarlyView.Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source